Takeda Pharmaceutical Company Limited (LON:0A87)

LON:0A87 Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	35,733	34,363	41,118	33,976	40,888	38,468
Market Cap Growth	-4.94%	-16.43%	21.02%	-16.91%	6.29%	-21.03%
Enterprise Value	61,320	60,110	66,084	56,723	71,294	76,134
Last Close Price	11.58	10.75	12.60	10.21	12.38	-
PE Ratio	33.80	45.57	21.33	23.57	16.57	116.48
PS Ratio	1.45	1.54	1.68	1.52	1.95	1.57
PB Ratio	0.89	0.90	1.06	0.95	1.20	1.09
P/FCF Ratio	7.23	12.14	8.08	5.42	6.92	9.50
P/OCF Ratio	5.95	9.16	6.92	4.83	6.16	7.69
EV/Sales Ratio	2.58	2.69	2.70	2.54	3.40	3.10
EV/EBITDA Ratio	8.99	10.09	8.98	7.65	11.04	11.59
EV/EBIT Ratio	20.05	23.28	17.54	15.09	25.62	34.38
EV/FCF Ratio	13.16	21.23	12.99	9.06	12.07	18.80
Debt / Equity Ratio	0.73	0.75	0.77	0.85	0.98	1.16
Debt / EBITDA Ratio	4.13	4.60	3.86	4.07	5.16	6.21
Debt / FCF Ratio	5.92	10.10	5.81	4.81	5.64	10.07
Asset Turnover	0.31	0.29	0.30	0.27	0.25	0.25
Inventory Turnover	1.31	1.30	1.36	1.40	1.34	1.33
Quick Ratio	0.59	0.50	0.49	0.73	1.00	0.65
Current Ratio	1.31	1.11	0.97	1.21	1.53	1.14
Return on Equity (ROE)	2.94%	2.12%	5.27%	4.24%	7.60%	0.89%
Return on Assets (ROA)	2.51%	2.12%	2.85%	2.88%	2.06%	1.39%
Return on Capital (ROIC)	2.97%	2.57%	3.57%	3.62%	2.59%	1.74%
Return on Capital Employed (ROCE)	4.50%	3.90%	5.40%	5.40%	3.80%	2.80%
Earnings Yield	2.96%	2.20%	4.69%	4.24%	6.04%	0.86%
FCF Yield	13.04%	8.24%	12.37%	18.44%	14.44%	10.53%
Dividend Yield	2.76%	9.15%	8.69%	11.05%	9.54%	-
Payout Ratio	145.09%	199.34%	88.14%	123.30%	75.36%	638.73%
Buyback Yield / Dilution	-1.17%	-0.67%	0.46%	-0.23%	-0.47%	-61.98%
Total Shareholder Return	1.59%	8.48%	9.15%	10.82%	9.07%	-61.98%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.